Literature DB >> 2969333

DNA-binding properties of an adenovirus 289R E1A protein.

P K Chatterjee1, M Bruner, S J Flint, M L Harter.   

Abstract

An adenovirus 2 289 amino acid (289R) E1A protein purified from Escherichia coli has been shown to interact with DNA by two independent methods. UV-crosslinking of complexes containing unmodified, uniformly 32P-labelled DNA and purified E1A protein induced efficient labelling of the protein with covalently attached oligonucleotides, indicating that the E1A protein itself contacts DNA. Discrete nucleoprotein species were also observed when E1A protein--DNA complexes were analysed by gel electrophoresis. Although the 289R E1A protein exhibited no significant binding to single-stranded DNA or to RNA, no evidence for its sequence-specific binding to double-stranded DNA was obtained with either assay. Identification of the sites of covalent attachment of 32P-labelled oligonucleotides by partial proteolysis of the crosslinked E1A protein indicated that the interaction of this protein with DNA is mediated via domain(s) in the C-terminal half of the protein. Such previously unrecognized DNA-binding activity is likely to contribute to the regulatory activities of this important adenoviral protein.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2969333      PMCID: PMC454399          DOI: 10.1002/j.1460-2075.1988.tb02882.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  40 in total

1.  Photochemical cross-linking of protein . nucleic acid complexes. The attachment of the fd gene 5 protein to fd DNA.

Authors:  P R Paradiso; Y Nakashima; W Konigsberg
Journal:  J Biol Chem       Date:  1979-06-10       Impact factor: 5.157

2.  Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis.

Authors:  D W Cleveland; S G Fischer; M W Kirschner; U K Laemmli
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

3.  Rous sarcoma virus transforming protein, p60src, expressed in E. coli, functions as a protein kinase.

Authors:  T M Gilmer; R L Erikson
Journal:  Nature       Date:  1981-12-24       Impact factor: 49.962

4.  Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis.

Authors:  M Fried; D M Crothers
Journal:  Nucleic Acids Res       Date:  1981-12-11       Impact factor: 16.971

5.  A restriction map of the bacteriophage T4 genome.

Authors:  P H O'Farrell; E Kutter; M Nakanishi
Journal:  Mol Gen Genet       Date:  1980

6.  Localization of the adenovirus E1Aa protein, a positive-acting transcriptional factor, in infected cells infected cells.

Authors:  L T Feldman; J R Nevins
Journal:  Mol Cell Biol       Date:  1983-05       Impact factor: 4.272

7.  Laser crosslinking of E. coli RNA polymerase and T7 DNA.

Authors:  C A Harrison; D H Turner; D C Hinkle
Journal:  Nucleic Acids Res       Date:  1982-04-10       Impact factor: 16.971

8.  DNA strand specificity in promoter recognition by RNA polymerase.

Authors:  C S Park; Z Hillel; C W Wu
Journal:  Nucleic Acids Res       Date:  1980-12-11       Impact factor: 16.971

9.  A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: application to components of the Escherichia coli lactose operon regulatory system.

Authors:  M M Garner; A Revzin
Journal:  Nucleic Acids Res       Date:  1981-07-10       Impact factor: 16.971

10.  Mutational analysis of the adenovirus E1a gene: the role of transcriptional regulation in transformation.

Authors:  J F Schneider; F Fisher; C R Goding; N C Jones
Journal:  EMBO J       Date:  1987-07       Impact factor: 11.598

View more
  31 in total

1.  Adenovirus protein VII condenses DNA, represses transcription, and associates with transcriptional activator E1A.

Authors:  Jeffrey S Johnson; Yvonne N Osheim; Yuming Xue; Margaux R Emanuel; Peter W Lewis; Alex Bankovich; Ann L Beyer; Daniel A Engel
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

2.  Interaction of a common factor with ATF, Sp1, or TATAA promoter elements is required for these sequences to mediate transactivation by the adenoviral oncogene E1a.

Authors:  S J Weintraub; D C Dean
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

3.  The downstream regulatory sequence of the adenovirus type 2 major late promoter is functionally redundant.

Authors:  X C Li; W L Huang; S J Flint
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

4.  Adenovirus E1A proteins are closely associated with chromatin in productively infected and transformed cells.

Authors:  Maurice Green; Ninder K Panesar; Paul M Loewenstein
Journal:  Virology       Date:  2007-11-26       Impact factor: 3.616

5.  A purified adenovirus 289-amino-acid E1A protein activates RNA polymerase III transcription in vitro and alters transcription factor TFIIIC.

Authors:  S Datta; C J Soong; D M Wang; M L Harter
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

6.  trans-dominant mutants of E1A provide genetic evidence that the zinc finger of the trans-activating domain binds a transcription factor.

Authors:  L C Webster; R P Ricciardi
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

7.  Adenovirus E1A protein activates transcription of the E1A gene subsequent to transcription complex formation.

Authors:  J Schaack; J Logan; E Vakalopoulou; T Shenk
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

Review 8.  Expression and interactions of human adenovirus oncoproteins.

Authors:  P A Boulanger; G E Blair
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

9.  The finger domain of simian virus 40 large T antigen controls DNA-binding specificity.

Authors:  A Höss; I F Moarefi; E Fanning; A K Arthur
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

10.  Transcription stimulation of the adenovirus type 12 E1a gene in vitro by the 266-amino-acid E1A protein.

Authors:  H Kawamura; N Wada; Y Makino; T A Tamura; S Koikeda; K Shiroki; Y Masamune; Y Nakanishi
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.